Stage IIA Cutaneous Melanoma AJCC v6 and v7
1 clinical trials · Condition
◉ Watch Stage IIA Cutaneous Melanoma AJCC v6 and v7
| Record | Firm | Date |
|---|---|---|
| Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery (NCT01989572) | National Cancer Institute (NCI) | 2000-02-23 |
Track Stage IIA Cutaneous Melanoma AJCC v6 and v7 automatically
Every clearance here is in the API, with alerts when new ones post.